• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Indirubin

Tumor genomes frequently contain somatic copy number alterations (SCNA) that can

June 20, 2017 by Katherine Lewis Leave a Comment

Tumor genomes frequently contain somatic copy number alterations (SCNA) that can significantly perturb the manifestation level of affected genes and thus disrupt pathways controlling normal growth. candidate genes potentially involved in tumorigenesis. Since few of these alterations were recurrent across our samples we used a protein network-guided approach to determine whether any pathways were TLK2 … [Read more…]

Posted in: Blogging Tagged: Indirubin, TLK2

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by